The Supreme Court on Thursday blocked opioid maker Purdue Pharma’s bankruptcy settlement which would have provided immunity to the Sackler family from facing lawsuits over their role in the opioid crisis.
Read MoreTag: Purdue Pharma
Former Head of OxyContin Giant Purdue Pharma Denies Fault or Blame in Opioid Crisis
The former president and board chair of Purdue Pharma testified in court on Wednesday that he, his family and the company are not at fault for the opioid crisis, CBS News reported.
Richard Sackler, 76, who is a member of the family that owns the OxyContin maker, denied responsibility at a White Plains, New York, bankruptcy hearing, CBS News reported.
Read MoreAttorney General Ellison Announces $50 Million Settlement with Purdue Pharma
Attorney General Keith Ellison announced Minnesota will get $50 million from the settlement of the state’s lawsuit against the Sackler family’s company Purdue Pharma, which manufactured the opioid drug Oxycontin that contributed to the deadly opioid crisis nationwide.
The resolution will make public more than 30 million documents related to Purdue’s role in the opioid crisis and require the Sacklers to pay $4.3 billion for prevention, treatment, and recovery efforts in communities across the country.
Minnesota’s share of those payments is expected to exceed $50 million over nine years, the spending of which will be overseen by the State’s Opioid Epidemic Response Advisory Council.
Read More15 States Reach Agreement, Pave Way for $4.5 Billion Settlement over Opioid Crisis
A coalition of 15 states agreed to a deal with drug maker Purdue Pharma, which could soon lead to a $4.5 billion settlement over the company’s role in the U.S. opioid epidemic.
The states agreed to no longer oppose Purdue Pharma’s bankruptcy plan while the pharmaceutical company agreed to publicly release a trove of millions of documents, according to a court filing late Wednesday night. The Sackler family, which owns the company, would pay an additional $50 million under the settlement.
The agreement will be tacked onto a broader proposal that is set to be voted on by more than 3,000 plaintiffs, The New York Times reported. In addition to the states, plaintiffs include cities, counties and tribes that sued the company over its role in boosting its painkiller OxyContin, the cause of thousands of opioid deaths.
Read MoreOxyContin Maker Purdue Pharma to Plead to Three Criminal Charges
Purdue Pharma, the company that makes OxyContin, the powerful prescription painkiller that experts say helped touch off an opioid epidemic, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion, Justice Department officials announced Wednesday.
The company will plead guilty to three counts, including conspiracy to defraud the United States and violating federal anti-kickback laws, the officials said. The resolution will be detailed in a bankruptcy court filing in federal court.
Read MoreReport: Purdue Pharma and Sackler Family Offer $12 Billion to Settle Opioids Lawsuit
Purdue Pharma and its owners, the Sackler family, reportedly offered between $10 billion and $12 billion to settle lawsuits over its role in the opioid crisis, during a meeting with at least 10 state attorneys general last week.
Read MoreMaker of OxyContin Agrees to $270M Settlement in Oklahoma
The maker of OxyContin and the company’s controlling family agreed Tuesday to pay a groundbreaking $270 million to Oklahoma to settle allegations they helped create the nation’s deadly opioid crisis with their aggressive marketing of the powerful painkiller. It is the first settlement to come out of the recent coast-to-coast…
Read MoreNew Info About Opioid-Profiteering Family Pushes Largest Museum in US to Rethink Gift Acceptance Policies
by Evie Fordham The Metropolitan Museum of Art is reviewing its gift acceptance policies after information that members of a prominent donor family headed a deceit campaign to push the highly addictive prescription opioid OxyContin, The Met told The Daily Caller News Foundation. Other New York City art museums…
Read More